PFKM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.227600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.259600E-01
Normal-vs-Stage2
7.326000E-01
Normal-vs-Stage3
6.637000E-01
Normal-vs-Stage4
4.187200E-01
Stage1-vs-Stage2
1.420640E-01
Stage1-vs-Stage3
1.213450E-01
Stage1-vs-Stage4
2.722000E-01
Stage2-vs-Stage3
2.972000E-01
Stage2-vs-Stage4
6.676600E-01
Stage3-vs-Stage4
3.012200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.111000E-01
Normal-vs-AfricanAmerican
4.515000E-01
Normal-vs-Asian
9.412800E-01
Caucasian-vs-AfricanAmerican
8.701000E-01
Caucasian-vs-Asian
4.145600E-01
AfricanAmerican-vs-Asian
4.677800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.991800E-01
Normal-vs-Female
6.429200E-01
Male-vs-Female
8.677400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.384200E-01
Normal-vs-Age(41-60Yrs)
3.783400E-01
Normal-vs-Age(61-80Yrs)
7.833600E-01
Normal-vs-Age(81-100Yrs)
5.954000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.604400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.725200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.198600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.471800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.987600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.826600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.424200E-01
Normal-vs-Daily Drinker
8.895200E-01
Normal-vs-Weekly Drinker
6.763800E-01
Normal-vs-Occasional Drinker
4.123000E-01
Normal-vs-Social Drinker
5.239800E-01
Non Drinker-vs-Daily Drinker
4.751400E-01
Non Drinker-vs-Weekly Drinker
2.133000E-01
Non Drinker-vs-Occasional Drinker
3.859500E-02
Non Drinker-vs-Social Drinker
1.213240E-01
Daily Drinker-vs-Weekly Drinker
4.690600E-01
Daily Drinker-vs-Occasional Drinker
8.639700E-02
Daily Drinker-vs-Social Drinker
2.163000E-01
Weekly Drinker-vs-Occasional Drinker
3.242400E-01
Weekly Drinker-vs-Social Drinker
4.939000E-01
Occasional Drinker-vs-Social Drinker
8.276600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.181800E-01
Normal-vs-Grade 2
2.789200E-01
Normal-vs-Grade 3
6.990000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.388400E-01
Grade 1-vs-Grade 3
2.095600E-01
Grade 1-vs-Grade 4
4.181800E-01
Grade 2-vs-Grade 3
4.561800E-01
Grade 2-vs-Grade 4
2.789200E-01
Grade 3-vs-Grade 4
6.990000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.381600E-01
Normal-vs-NonDiabetic
6.789000E-01
Diabetic-vs-NonDiabetic
9.037800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.480000E-01
Normal-vs-NoPancreatitis
6.708000E-01
Pancreatitis-vs-NoPancreatitis
8.585200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.433000E-01
Normal-vs-N1
7.264200E-01
N0-vs-N1
1.795430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.612400E-01
Normal-vs-TP53-NonMutant
5.123600E-01
TP53-Mutant-vs-TP53-NonMutant
1.907580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
